Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:51-56
Published online before print May 12, 2008, doi: 10.1161/HYPERTENSIONAHA.107.090472
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/1/51    most recent
HYPERTENSIONAHA.107.090472v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welch, W. J.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2008;52:51.)
© 2008 American Heart Association, Inc.


Hypertension Highlights

Angiotensin II–Dependent Superoxide

Effects on Hypertension and Vascular Dysfunction

William J. Welch

From the Department of Medicine, Georgetown University, Washington, DC.

Correspondence to William J. Welch, Department of Medicine, Georgetown University, 4000 Reservoir Rd, Building D-395, Washington, DC 20007. E-mail welchw@georgetown.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Angiotensin (Ang) II generates reactive oxygen species (ROS) by activation of Ang II type 1 receptors (AT1Rs). The resulting ROS mediates many of the actions of Ang II, including constriction of vascular smooth muscles, increased systemic blood pressure (BP), endothelial dysfunction, vascular remodeling, and sodium retention. Ang II has its greatest effect on superoxide anion (O2), which may be an important signaling element of the hypertensive rats and other deleterious actions of Ang II. The mechanisms of ROS actions are not fully understood, yet effective antioxidant therapy often attenuates hypertension and other vascular effects of Ang II. Currently many studies use Ang II–infused animal models to investigate the role of ROS and interacting systems, not only on hypertension, but endothelial dysfunction, renal disease, heart disease, and other pathologies. This review focuses on the recent reports of Ang II–generated ROS and how it impacts hypertension and its vascular consequences.


*    Mechanism of Ang II Generation of O2
 
Superoxides are formed by several oxidases and oxygenases and incomplete mitochondrial oxidative phosphorylation. The major source of O2 that impacts the vasculature and systemic BP is reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase, which is abundantly expressed in vascular smooth muscle cells. Five isoforms of NADPH oxidase (Nox) have been identified in animals: Nox1 to Nox5, with Nox1, Nox2, and Nox4 expressed in vascular cells. Nox isoforms are composed of 2 to 5 subunits: 2 membrane-bound subunits, gp91phox and p22phox, and cytosolic subunits p47phox, p67phox, and Rac-1 (reviewed in Mehta and Griendling1). Ang II upregulates several subunits . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cancer Res.Home page
U. Schmid, H. Stopper, F. Schweda, N. Queisser, and N. Schupp
Angiotensin II Induces DNA Damage in the Kidney
Cancer Res., November 15, 2008; 68(22): 9239 - 9246.
[Abstract] [Full Text] [PDF]